Navigation Links
Early Detection Of Primary Liver Cancer Would Save Millions Of Lives

Researchers at the University of Birmingham had developed a new technology that will help in the early diagnosis of liver cancer among people who are at a high risk. It is a blood test, which measures the protein levels // combined with the computer analysis, which can detect typical; changes seen in the early liver cancer patients.

This discovery would save millions of lives because live cancer is one of the most prevalent diseases. If it were diagnosed in the early stage then it would be easy to treat the patient. The findings of the research were published in the British Journal of Cancer.

Hepatocellular carcinoma or liver cancer is the sixth most common cancer in the world and it is widespread in East Asia. Usually people with cirrhosis of the liver are more prone to develop liver cancer and hence highly sensitive tests are required to detect the disease and prevent it among the patients suffering from liver cirrhosis.

Professor Philip Johnson said that through this research they were able to distinguish people who had early liver cancer from those who without the disease. This method is very accurate and sensitive than any of the present techniques such as the existing liver cancer blood test.

But further studies have to be performed so that the test can be performed on many people.

Apart from cirrhosis of the liver various disease that cause damage to the liver like the hepatitis B and C viruses, causing Hepatitis greatly increase the risk of hepatocellular carcinoma.

Vaccinations against the hepatitis B virus are now administered to children to protect them against the disease, but there are millions of people who are already infected with the disease. In case of hepatitis C, there is no effective vaccine and the incidence of liver cancer still remains high in the global scenario.

At present high-risk groups can be screened with the help of ultrasound scans and test for the presence of a single protein in the blood called alpha-fetoprotein. Though it is a good indicator of advanced stages of the liver cancer, but it is a poor indicator of early stage liver cancer.


'"/>




Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early therapy aids eyesight
11. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... May 27, 2016 , ... ... help educate the many who are unaware of the plight of aphasia. In ... run within the “Stroke Awareness” campaign. , The link between stroke and aphasia ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... in scholarships to students studying complementary medicine. Allison Outerbridge is this year’s ... her award on May 18 at the university’s Student Leadership Awards ceremony. , ...
(Date:5/26/2016)... ... , ... Despite last week’s media reports hinting at a June rate hike ... March 2017 for an interest rate increase, according to Rajeev Dhawan of the Economic ... Federal Open Market Committee (FOMC) dot charts are of interest to the press for ...
(Date:5/26/2016)... New Hampshire (PRWEB) , ... May 26, 2016 , ... ... skin care products, has been honored with a 2016 When Work Works Award for ... prestigious award, part of the national When Work Works project administered by the Families ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... , May 25, 2016 ... & Expo earlier this month, the numbers and momentum ... continue to climb into the billions, more research and ... released 4th Edition State of Legal Marijuana Markets Report ... cannabis-focused data-analysis firm, much of the increase in sector ...
(Date:5/25/2016)... May 25, 2016 Inivata, ... precision of circulating tumour DNA (ctDNA) analysis to ... appointment of Professor Clive Morris as ... across the clinical development programme, scientific collaborations, and ... deliver significant improvements in clinical outcomes for patients. ...
Breaking Medicine Technology: